Cargando…

Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis

Detalles Bibliográficos
Autores principales:	Saur, Sebastian-Jonas, Horger, Marius, Henes, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Letter to the Editor (Case report)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878844/ https://www.ncbi.nlm.nih.gov/pubmed/33604503 http://dx.doi.org/10.1093/rap/rkaa082

Ejemplares similares

Increased Circulating Th17 Cells, Serum IL-17A, and IL-23 in Takayasu Arteritis
por: Misra, Durga Prasanna, et al.
Publicado: (2016)

Targeting IL12/23 in ulcerative colitis: update on the role of ustekinumab
por: Pugliese, Daniela, et al.
Publicado: (2022)

Tofacitinib in patients with refractory Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2020)

Successful Use of Tofacitinib in Refractory Takayasu Arteritis: A Case Series
por: MV, Prakashini, et al.
Publicado: (2023)

Systematic review: IL-12/23 or IL-23 antagonists and RTIs or ILD
Publicado: (2020)

A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production
por: Nakajima, Toshiki, et al.
Publicado: (2017)

A susceptibility locus in the IL12B but not LILRA3 region is associated with vascular damage in Takayasu arteritis
por: Kadoba, Keiichiro, et al.
Publicado: (2021)

IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events
por: Gu, Stephanie L., et al.
Publicado: (2023)

Takayasu Arteritis
por: Russo, Ricardo A. G., et al.
Publicado: (2018)

Remission Achieved in Refractory Advanced Takayasu Arteritis Using Rituximab
por: Ernst, D., et al.
Publicado: (2012)

Takayasu arteritis in children
por: Al abrawi, Safia, et al.
Publicado: (2008)

Takayasu's arteritis in childhood
por: Brunner, J
Publicado: (2008)

Takayasu arteritis in an infant
por: Sandeep, S., et al.
Publicado: (2014)

Scleritis in Takayasu Arteritis
por: Chittipolu, Swetha, et al.
Publicado: (2023)

Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib
por: Yamamura, Yuriko, et al.
Publicado: (2019)

Indirect Regulation and Equilibrium of p35 and p40 Subunits of Interleukin (IL)-12/23 by Ustekinumab in Psoriasis Treatment
por: Zhou, Jiong, et al.
Publicado: (2020)

Ustekinumab in Psoriasis Immunopathology with Emphasis on the Th17-IL23 Axis: A Primer
por: Quatresooz, Pascale, et al.
Publicado: (2012)

Successful Treatment of Refractory Autoimmune Enteropathy With Ustekinumab
por: Scheid, Johannes F., et al.
Publicado: (2021)

Surgical Management of Takayasu's Arteritis
por: Joh, Jin-Hyun, et al.
Publicado: (2006)

FDG-PET of Takayasu’s Arteritis
por: Shikino, Kiyoshi, et al.
Publicado: (2014)

Bentall procedure in Takayasu arteritis
por: Hidiroglu, M, et al.
Publicado: (2013)

Recurrent Vertigo: Is it Takayasu's Arteritis?
por: Ashutosh, Tiwari, et al.
Publicado: (2013)

5. Paediatric Takayasu arteritis
por: Mackay, Madeleine, et al.
Publicado: (2018)

“Macaroni Sign” in Takayasu Arteritis
por: Ghembaza, Mohammed El Amine, et al.
Publicado: (2018)

Intracranial Involvement in Takayasu’s Arteritis
por: Johnson, Andrea, et al.
Publicado: (2021)

Novel Therapies in Takayasu Arteritis
por: Regola, Francesca, et al.
Publicado: (2022)

Takayasu Arteritis Mimicking Phlegmon
por: Taira, Yuki, et al.
Publicado: (2022)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Refractory Case of Takayasu Arteritis in a Young Woman: A Clinical Challenge
por: Ahmed, Mudassar, et al.
Publicado: (2016)

Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis: Two case reports
por: Asano, Tomoyuki, et al.
Publicado: (2020)

Refractory renovascular hypertension secondary to Takayasu arteritis treated with aorto-mesenteric bypass
por: Jimenez, Daniel, et al.
Publicado: (2022)

Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review
por: Li, Haiyan, et al.
Publicado: (2021)

Refractory Takayasu’s Arteritis with Severe Coronary Involvement—Case Report and Literature Review
por: Cobilinschi, Claudia Oana, et al.
Publicado: (2023)

Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 years
por: Fukui, Shoichi, et al.
Publicado: (2016)

The Dichotomous Pattern of IL-12R and IL-23R Expression Elucidates the Role of IL-12 and IL-23 in Inflammation
por: Chognard, Gaëlle, et al.
Publicado: (2014)

Pyoderma Gangrenosum and Erythema Nodosum Revealing Takayasu's Arteritis
por: Loetscher, Jonas, et al.
Publicado: (2016)

Successful spinal anaesthesia for caesarean section in an African patient with Takayasu’s arteritis
por: Kassa, Mamo Woldu, et al.
Publicado: (2018)

Ustekinumab for Successful Treatment of Refractory Esophageal Crohn’s Disease
por: Barkin, Jodie A., et al.
Publicado: (2016)

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tiessbjg6bos595jche5cc0e0s